The trademark application LONATEVIR was filed by Takeda Pharmaceuticals International AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on September 24, 2020, and it was registered by office on January 7, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).